View full meeting coverage »

Eyetube Meeting Coverage:

2017 Retina World Congress Meeting

You are watching a 25-second preview
Log in to keep watching

You are watching a 25-second preview Log in to keep watching

You are watching a 25-second preview
Log in to keep watching

Replay

Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Anti-VEGF Therapy and Vitrectomy in Severe PDR

J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group’s collaboration with other groups.

6 / 12 Series: 2017 Retina World Congress Meeting

J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group’s collaboration with other groups.

Keywords

Comments view all

. United States - today

Post Comment
post as anonymous

More Videos in this Series

1

Abicipar Pegol in Phase 2

Pravin Dugel, MD

OCTA in DR

Nadia Waheed, MD

Managing TRDs

Maria H. Berrocal, MD

Diagnosis and Treatment of FEVR

Ehab El-Rayes, MD

Widefield Imaging and OCT

Netan Choudhry, MD

Anti-VEGF Therapy and Vitrectomy in Seve…

Peeling ERM in Patients With Good Vision

Andre Gomes, MD

Welcome to the Retina World Congress!

Rishi P. Singh, MD

How Long-Term RVO Patients Respond to Th…

Antonio Casella, MD, PhD

Early Intervention in PDR and Vitreous H…

Francesco Boscia, MD

Multimodal Imaging in Ocular Oncology

Prithvi Mruthyunjaya, MD

View full meeting coverage (12 videos)

1

Peeling ERM in Patients With Good Vision

Andre Gomes, MD

Welcome to the Retina World Congress!

Rishi P. Singh, MD